Back

Gender differences in the treatment with PCSK9 monoclonal antibodies real world experience from a dedicated prevention clinic

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Gender differences in heart disease Drug therapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Lital Hodeda

Rabin Medical Centre, Petah Tikva (Israel)

5 More presentations in this session

Presentation thumbnail
Gender disparities and infective endocarditis burden in the United States and European Union: a comparative analysis
Doctor M. Petrovic (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Traditional cardiovascular risk factors and coronary microvascular disease in women and men- a single center study
Doctor L. Zornitzki (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Interaction between subclinical carotid atherosclerosis endotype and biological sex: a study from IMPROVE cohort
Mr Q. Chen (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Is there a gender difference in the effects of cardiovascular risk factors on the anatomical localization and severity of obstruction on coronary arteries?
Doctor A. Erdem (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Sex differences in secondary prevention and outcomes post-myocardial infarction in Scotland.
Doctor T. Pana (Aberdeen, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Gender differences in heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Sex-specific guideline target value attainment and prognostic value of low-density lipoprotein cholesterol in tertiary care
thumbnail
Congress Presentation
Sex differences in management of LDL-cholesterol in patients with chronic coronary syndrome
thumbnail
Congress Presentation
Proprotein convertase subtilisin/kexin type 9 levels and the risk of cardiovascular events in statin-treated patients with cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources